Position in LLY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$666,238,158
-$136,791,827 QoQ
Shares Held
724,353
-3.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $3,186,364,161 across 12 Drug Manufacturers - General names. LLY ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
724,353 | $666,238,158 | |
| 2 | JNJ |
Johnson & Johnson
|
2,605,500 | $636,888,419 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,665,193 | $561,176,064 | |
| 4 | ABBV |
AbbVie Inc.
|
2,207,913 | $480,198,997 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,422,423 | $207,569,953 | |
| 6 | AMGN |
Amgen Inc
|
534,443 | $188,043,767 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,100,253 | $153,342,259 | |
| 8 | PFE |
Pfizer Inc
|
5,302,261 | $148,887,487 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $666,238,158 | 724,353 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $803,029,985 | 747,227 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $644,737,289 | 845,003 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $696,787,566 | 893,856 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $755,027,098 | 914,176 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $721,479,548 | 934,559 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $856,542,738 | 966,818 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $950,348,413 | 1,049,668 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $863,821,887 | 1,110,368 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $640,113,194 | 1,098,115 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $553,616,667 | 1,030,694 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $399,072,900 | 850,938 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $275,169,050 | 801,261 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $295,993,093 | 809,078 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $282,906,348 | 874,923 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $247,800,556 | 764,274 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $215,616,560 | 752,930 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $219,594,897 | 795,000 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $186,852,442 | 808,710 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $185,616,265 | 808,715 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $117,740,875 | 630,237 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $104,605,326 | 619,553 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $188,505,095 | 1,273,511 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $221,849,864 | 1,351,260 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $262,525,100 | 1,892,482 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||